Our Core business is manufacturing high quality and affordable generic APIs and currently we offer a wide range of APIs in different treatment segments . With 30 molecules under development, Parsian is continuously extending its portfolio by focusing on molecules in diverse fields such as oncology, cardio vascular and diabetes. Parsian pharma is trusted for most difficult to manufacture compounds and several major finished dosage manufacturers rely on our expertise with structurally complex oncology small molecule TKIs.


We also offer integrated solutions, unique scientific and advanced technical services across the drug lifecycle, from pipeline selection and development to commercial manufacturing of drug substances and drug products. Our team of experts work closely with you to translate your ideas and projects at any stage of development into products with interesting market potential.